Bridgebio Pharma, Inc. (BBIO) SEC Filings — 2024

Filings

• BridgeBio Pharma Files 8-K for Other Events — 8-K · Nov 25, 2024
• Bridgebio Pharma, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• BridgeBio Pharma Q3 2024 Update — 10-Q · Nov 12, 2024
• Viking Global Investors Amends BridgeBio Pharma Stake — SC 13D/A · Nov 6, 2024
• Bridgebio Pharma, Inc. SC 13G/A Filing — SC 13G/A · Oct 22, 2024
• KKR Entity Amends Stake in BridgeBio Pharma — SC 13D/A · Sep 17, 2024
• BridgeBio Pharma Files 8-K — 8-K · Sep 11, 2024
• BridgeBio Pharma Enters Material Definitive Agreement — 8-K · Aug 21, 2024
• Viking Global Investors LP Amends BridgeBio Pharma Stake — SC 13D/A · Aug 20, 2024
• BridgeBio Pharma Files Q2 2024 10-Q — 10-Q · Aug 1, 2024
• BridgeBio Pharma Elects New Directors, Discloses Executive Compensation — 8-K · Jul 23, 2024
• BridgeBio Pharma Files 8-K on Shareholder Votes and Exhibits — 8-K · Jun 24, 2024
• BridgeBio Pharma Files 8-K Report — 8-K · Jun 6, 2024
• BridgeBio Pharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
• BridgeBio Pharma, Inc. Announces 2024 Annual Meeting of Stockholders on June 21, 2024 — DEF 14A · Apr 25, 2024
• BridgeBio Pharma Files 8-K: Material Agreement Announced — 8-K · Mar 6, 2024
• BridgeBio Pharma Enters Material Definitive Agreement — 8-K · Mar 4, 2024
• BridgeBio Pharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 22, 2024
• Bridgebio Pharma, Inc. SC 13G/A Filing — SC 13G/A · Feb 16, 2024
• Bridgebio Pharma, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• BlackRock Amends BridgeBio Pharma Stake as of Dec 31, 2023 — SC 13G/A · Jan 29, 2024
• State Street Corp. Updates Passive Stake in BridgeBio Pharma — SC 13G/A · Jan 23, 2024
• BridgeBio Pharma: Material Agreement Entered & Terminated, New Obligation — 8-K · Jan 18, 2024
• BridgeBio Pharma Files 8-K for 'Other Events,' Rule 425 Comms — 8-K · Jan 8, 2024